2012 ACCP Annual Meeting: Scientific Poster Presentations, III

22E

Impact of a High-Fat Meal on Assessment of Clopidogrel-Induced Platelet Inhibition in Healthy Subjects

Paul P. Dobesh, Pharm.D.¹, Jamela Urban, Pharm.D.², Scott Shurmur, MD² and Julie H. Oestreich, PharmD, PhD³
1University of Nebraska Medical Center, Omaha, NE
2The Nebraska Medical Center, Omaha, NE
3Department of Pharmacy Practice, University of Nebraska Medical Center, Omaha, NE

23

Perceptions, knowledge, and patterns of use of "fish oil" products in cardiac patients

Elizabeth B. Hawkins, PharmD¹, Hua Ling, PharmD², Tammy L. Burns, PharmD² and Daniel E. Hilleman, PharmD, FCCP³
1Creighton University Medical Center, Omaha, NE
2Creighton University Cardiac Center, Creighton University School of Medicine, Omaha, NE
3Department of Pharmacy Practice, Creighton University School of Pharmacy and Health Professions, Omaha, NE

24

Aliskiren in patients failing to achieve blood pressure targets with angiotensin converting enzyme inhibitors or angiotensin receptor blockers

Elizabeth B. Hawkins, PharmD¹, Hua Ling, PharmD², Tammy L. Burns, PharmD², Aryan Mooss, MD³ and Daniel E. Hilleman, PharmD, FCCP⁴
1Creighton University Medical Center, Omaha, NE
2Creighton University Cardiac Center, Creighton University School of Medicine, Omaha, NE
3The Cardiac Center of Creighton University, Creighton University School of Medicine, Omaha, NE
4Department of Pharmacy Practice, Creighton University School of Pharmacy and Health Professions, Omaha, NE

25

Discordance between regression-derived and ATP III table-derived Framingham 10-year risk: A P.A.T.H. Substudy

Steven M. Smith, PharmD, MPH¹, Nancy Borja-Hart, PharmD², Audrey Wooten, MD³ and Benjamin J. Epstein, Pharm.D.⁴
1University of Colorado, Aurora, CO
2East Coast Institute for Research, Jacksonville, FL
3St. Vincent's Hospital, Jacksonville, FL
4University of Florida, Gainesville, FL

26

Impact of safety alerts on prescribing patterns of simvastatin and atorvastatin in an outpatient cardiac specialty centre in Singapore

Chai Ling Ong, BSc(Pharm)(Hons), Jacqueline Peck Sze Wong, B.Sc.Pharm.(Hons), Shera See Ah Wong, B.Sc.Pharm.(Hons), Huey Shyan Yong, B.Sc.Pharm.(Hons), Jin Shing Hon, B.Sc.Pharm.(Hons), Siew Chong Teo, M.Pharm.(Clin Pharm) and Chi Keong Ching, FAMS (Cardiology)
National Heart Centre Singapore, Singapore, Singapore

27

Effectiveness and safety of rivaroxaban compared to enoxaparin for thromboprophylaxis in orthopedic patients

Vimala Sivapragasam, Pharm.D., BCPS, Teena Abraham, Pharm.D., BCPS, Nasser Saad, Pharm.D., Henry Tischler, M.D. and Eric Balmir, Pharm.D.
New York Methodist Hospital, Brooklyn, NY

28

The relative bioavailability of single-dose rivaroxaban, a novel oral anticoagulant and a selective direct factor Xa inhibitor, administered orally (as a whole or crushed tablet) and via nasogastric tube (as a crushed tablet suspension)

Kenneth T. Moore, MS¹, Seema Vaidyanathan, MS¹, Chandrasekharrao V. Damaraju, PhD² and Larry E. Fields, MD, MBA, FAHA, FACC³
1Janssen Research & Development, LLC, Titusville, NJ
2Janssen Research & Development, LLC, Raritan, NJ
3Janssen Scientific Affairs, LLC, Raritan, NJ

29

Factors Influencing Physicians' Selection of Dabigatran in Non-valvular Atrial Fibrillation

Cindy Huang, PharmD, Michele Siu, PharmD, Lily Vu, PharmD, Soo Wong, PharmD and Jaekyu Shin, Pharm.D.
University of California San Francisco, San Francisco, CA

30

Comparison of the risk of bradycardia between two oral metoprolol formulations

Jaekyu Shin, Pharm.D.¹, Marco Gonzales, PharmD² and Mark Pletcher, MD¹
1University of California San Francisco, San Francisco, CA
2California Department of Health Care Services, Sacramento, CA

31

Heart Failure Patients Demographics at an Inner City Safety Net Hospital

Andrew Smith, Pharm.D., BCPS (AQ-CV)¹, Darcy Green-Conaway, M.D.² and Mark E. Patterson, Ph.D, M.P.H.³
1UMKC School of Pharmacy, Kansas City, MO
2Truman Medical Center, Kansas City, MO
3University of Missouri-Kansas City School of Pharmacy, Kansas City, MO

32

Impact of worsening renal function on resource utilization and medications after diuretic dose escalation in a chronic heart failure ambulatory population

Vicki L. Groo, PharmD¹, Anita Lammers, PharmD², Daniel Touchette, PharmD, MA¹ and Thomas D. Stamos, MD¹
1University of Illinois at Chicago, Chicago, IL
2Illinois Masonic Medical Center, Chicago, IL

33

Baseline Albumin Predicts Worsening Renal Function in Acute Decompensated Heart Failure Patients receiving Continuous Infusion Loop Diuretics

Megan M. Barnes, PharmD, BCPS¹, Michael P. Dorsch, PharmD, MS, BCPS, (AQ, CV)², Susie Kim, PharmD³, Keith Aaronson, M.D., M.S.², Todd Koelling, M.D.² and Barry E. Bleske, PharmD, FCCP⁴
1Allegheny General Hospital, Pittsburgh, PA
2University of Michigan Hospitals and Health Centers, Ann Arbor, MI
3Eli Lily & Company, Indianapolis, IN
4University of Michigan, Ann Arbor, MI

34E

Stability of levosimendan during simulated y-site administration

Wayne S. Moore II, Pharm.D.¹, Jeffrey J. Cies, Pharm.D., BCPS², Michael A. McCulloch, M.D.¹, Deborah A. Davis, M.D.¹ and Robert W. Mason, Ph.D³
1Alfred I. duPont Hospital for Children/Nemours Cardiac Center, Wilmington, DE
2St. Christopher's Hospital for Children, Philadelphia, PA
3Alfred I. duPont Hospital for Children/Nemours Biomedical Research, Wilmington, DE

35

The effect of continuous infusion loop diuretics in acute decompensated heart failure patients with hypoalbuminemia

Michael P. Dorsch, PharmD, MS, BCPS, (AQ, CV)¹, Megan M. Barnes, PharmD², Audrey H. Wu, MD¹ and Barry E. Bleske, PharmD, FCCP³
1University of Michigan Hospitals and Health Centers, Ann Arbor, MI
2Allegheny General Hospital, Pittsburgh, PA
3University of Michigan, College of Pharmacy, Ann Arbor, MI

36

The effects of universal fibrate discontinuation on management of dyslipidemia at the Portland Veterans Affairs Medical Center (PVAMC)

Mariah D. Alford, Pharm.D.¹, Jessina C. McGregor, PhD² and Harleen Singh, Pharm.D.²
1Portland Veterans Affairs Medical Center, Portland, OR
2Oregon State University/Oregon Health & Science University College of Pharmacy, Portland, OR

37

A pilot feasibility study to assess knowledge and behaviors related to warfarin therapy

Kathryn M. Momary, Pharm.D., BCPS, Nicole L. Metzger, Pharm.D., BCPS, Kevin Sponsel, Pharm.D. Candidate and Annette Daehler, Pharm.D. Candidate
Mercer University College of Pharmacy and Health Sciences, Atlanta, GA

38

The Effects of Carvedilol in Patients with Cocaine-Induced Chest Pain

Shannon W. Finks, Pharm.D.¹, Corry T. Johnston, Pharm.D.², Robert B. Parker, Pharm.D.¹ and Kelly C. Rogers, Pharm.D.¹
1University of Tennessee College of Pharmacy, Memphis, TN
2Veterans Affairs Medical Center, Memphis, TN

39

Thromboxane and Prostaglandin Metabolite Levels and Inflammation Phenotypes in Coronary Artery Disease Patients

Brian Simmons, PharmD, MSCR¹, Robert N. Schuck, Pharm.D.¹, Kimberly Molnar, BS¹, Savanna Steele, Pharm.D.¹, Melissa Caughey, R.V.T., M.P.H.², Alan L. Hinderliter, M.D.², George A. Stouffer, M.D.² and Craig R. Lee, Pharm.D., Ph.D.¹
1Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC
2Division of Cardiology; School of Medicine, University of North Carolina, Chapel Hill, NC

40

Racial differences in anticoagulation control and risk of hemorrhage among warfarin users

Jonathan L. Thigpen, Pharm.D.¹, Qi Yan, M.S.², Nianjun Liu, Ph.D.³, Mark Beasley, Ph.D.³ and Nita A. Limdi, Pharm.D., Ph.D.¹
1University of Alabama at Birmingham, Department of Neurology, Birmingham, AL
2University of Alabama at Birmingham, School of Public Health, Birmingham, AL
3University of Alabama at Birmingham, Department of Biostatistics, Birmingham, AL

42

Balance of Academic Responsibilities of Clinical Track Pharmacy Faculty in the US

Edith A. Nutescu, PharmD¹, Robert DiDomenico, Pharm.D.¹, Sacheeta Bathija, BS, Pharm¹, Shellee Grim, PharmD¹, Jeffrey Mucksavage, PharmD¹, Eljim Tesoro, PharmD¹, Kirsten Ohler, PharmD¹, James Thielke, PharmD¹, Juliana Chan, PharmD², Nancy Shapiro, PharmD¹ and Janet Engle, PharmD¹
1University of Illinois at Chicago College of Pharmacy, Department of Pharmacy Practice, Chicago, IL
2University of Illinois at Chicago College of Pharmacy, Chicago, IL

49

Student performance and faculty perception after transition to team-based learning in a drug-induced disease elective

Sarah A. Treadway, PharmD, BCPS¹, Michelle Z. Farland, PharmD, BCPS² and Shaunta' Ray, Pharm.D., BCPS²
1Auburn University Harrison School of Pharmacy, Mobile, AL
2University of Tennessee College of Pharmacy, Knoxville, TN

50

Use of a unified learning style model to improve student self-directed learning in pharmacy students

Christopher A. Giuliano, PharmD¹, Jessica L. Jones, PharmD¹, Emily T. Martin, MPH, PhD¹, Vickie Poremba, PharmD² and Lynette R. Moser, PharmD¹
1Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, MI
2Sparrow Hospital, Lansing, MI

51

Tracking the Development of Student Self-Efficacy to Perform Clinical Pharmacy Tasks

Stuart T. Haines, Pharm.D., BCPS, David Roffman, Pharm.D., BCPS, Lisa Lebovitz, J.D. and Deborah A. Sturpe, PharmD, BCPS
University of Maryland School of Pharmacy, Baltimore, MD

52

Academic workload: what the heck are we doing?

Kamila A. Dell, PharmD, BCPS, Marianne E. Koenig, PharmD, BCPS, Erini S. Serag, PharmD, Amanda M. DeBruin, PharmD, BCPS, CGP, Jose L. Barboza, PharmD, Aimon C. Miranda, PharmD, Shyam R. Gelot, PharmD and L. Douglas Ried, PhD
University of South Florida College of Pharmacy, Tampa, FL

53

Attitudes and Perceptions of Postgraduate Residents and Fellows in Telemedicine Services at the University of Illinois at Chicago College of Pharmacy

Melissa E. Badowski, PharmD¹ and Chessa R. Nyberg, PharmD²
1University of Illinois at Chicago College of Pharmacy, Chicago, IL
2University of Illinois at Chicago, Chicago, IL

54

An evaluation of student drug literature evaluations skills by comparing student performance on journal club presentations and application based biostatistics questions

Jean E. Cunningham, PharmD and Laura Perry, PharmD
The University of Findlay College of Pharmacy, Findlay, OH

55

Facebook activity and views regarding E-Professionalism: a survey of pharmacy students in Qatar

Maguy S. El Hajj, PharmD, Tasnim Abd Al Halim Massoud, BSc, Pharm, Candidate and Atefeh Gholamhussain Moeinzadeh, BSc, Pharm, Candidate
Qatar University College of Pharmacy, Doha, Qatar

56

Students' perceptions of the effect of pharmacotherapeutics workshops on clinical skills practiced on advanced pharmacy practice experiences

Jennifer J. D'Souza, Pharm.D., CDE, BC-ADM¹, Kathy E. Komperda, Pharm.D., BCPS¹, Jill S. Borchert, PharmD, BCPS, FCCP², Jacob P. Gettig, Pharm.D., MPH, BCPS¹, Meri Hix, Pharm.D., BCPS, CGP³, Tudy Hodgman, Pharm.D., BCPS, FCCM¹ and Timothy Todd, Pharm.D.¹
1Midwestern University Chicago College of Pharmacy, Downers Grove, IL
2Dreyer Medical Clinic & Midwestern University Chicago College of Pharmacy, Downers Grove, IL
3Texas Tech University Health Sciences Center School of Pharmacy, Abilene, TX

57

Evaluation of Improved Evidence-Based Patient Care Application During a Primary Care Advanced Practice Experience

Kelly Hester, Pharm.D., BCPS, AAHIVE¹, Dana G. Carroll, PharmD² and Kristi Kelley, PharmD, BCPS, CDE³
1Auburn University Harrison School of Pharmacy, Auburn, AL
2Auburn University Harrison School of Pharmacy, Tuscaloosa, AL
3Auburn University, Harrison School of Pharmacy, Birmingham, AL

58E

Evaluation of clinical skills with an objective structured clinical examination

Elizabeth M. Urteaga, PharmD, Rebecca Attridge, Pharm.D., MS., BCPS, John Tovar, PharmD and Amy Witte, PharmD
University of the Incarnate Word Feik School of Pharmacy, San Antonio, TX

59

Standardized approach to patient-based pharmacotherapy notes in a therapeutics course

Angela O. Shogbon, PharmD, BCPS, Lisa M. Lundquist, PharmD, BCPS and Kathryn M. Momary, PharmD, BCPS
Mercer University College of Pharmacy and Health Sciences, Atlanta, GA

60

Student perceptions of team-based learning activities in a critical care elective as preparation for advanced practice pharmacy experiences

Katie E. Ronald, Pharm.D.
Southern Illinois University Edwardsville School of Pharmacy, Edwardsville, IL

61

Development and evaluation of a team-taught academic advanced pharmacy practice experience (APPE)

Sandra Benavides, Pharm.D.¹, Antonia Zapantis, PharmD, MS¹, Jehan Marino, PharmD¹, Jennifer G. Steinberg, PharmD¹, Elizabeth Sherman, PharmD¹, Angela S. Garcia, PharmD¹, Nancy Borja-Hart, PharmD² and Joshua Caballero, PharmD¹
1Nova Southeastern University, College of Pharmacy, Davie, FL
2East Coast Institute for Research, Jacksonville, FL

62

Impact of a Residency Interviewing Preparatory Seminar (RIPS) elective in securing post-doctoral training

Joshua Caballero, PharmD¹, Sandra Benavides, Pharm.D.¹, Kevin A. Clauson, Pharm.D.², Jennifer G. Steinberg, PharmD¹, Timothy P. Gauthier, PharmD¹, Shara Elrod, PharmD¹ and Jehan Marino, PharmD¹
1Nova Southeastern University, College of Pharmacy, Davie, FL
2Nova Southeastern University, College of Pharmacy - West Palm Beach, USA, Palm Beach Gardens, FL

63

Patient care impact and potential cost avoidance generated by student pharmacists during Advanced Pharmacy Practice Experiences

Adam B. Woolley, Pharm.D., BCPS¹, Roger A. Edwards, ScD², Charles A. Berds IV, BS, Pharm² and Margarita V. DiVall, Pharm.D., BCPS²
1School of Pharmacy, Northeastern University, Boston, MA
2Northeastern University School of Pharmacy, Boston, MA

64

Use of Pre- and Post-Tests to Assess Student Pharmacist Effectiveness when Presenting In-services to Other Health Care Professionals

Amber N. McLendon, PharmD¹ and C. Brock Woodis, PharmD²
1Campbell University College of Pharmacy and Health Sciences and Glenaire, Inc. CCRC, Buies Creek, NC
2Campbell University College of Pharmacy and Health Sciences and Duke University Department of Community and Family Medicine, Durham, NC

65

The impact of objective structured clinical examination on pharmacy intern training program

Shu-Hsien Wu, B.S., Yun-Ting Pan, B.S., Ming-Shya Wan, M.S. and Shu-Hui Sun, M.S.
Department of Pharmacy, Far Eastern Memorial Hospital, New Taipei City, Taiwan

66

Interventions by student pharmacists in an outpatient teaching family medicine center

Miranda R. Andrus, Pharm.D., BCPS and T. Lynn Stevenson, PharmD, BCPS, CDM
Auburn University Harrison School of Pharmacy, Auburn, AL

67

Impact of a virtual patient pilot program on student pharmacists' learning outcomes

Mark A. Douglass, Pharm.D.¹, Jillian Casale, PharmD, candidate², Margarita V. DiVall, Pharm.D., BCPS² and J. Andrew Skirvin, PharmD, BCOP²
1Northeastern University Department of Pharmacy Practice/Boston Medical Center, Boston, MA
2Northeastern University School of Pharmacy, Boston, MA

68

Evaluation of a Strategy to Build Competency in a Drug Literature Evaluation Course

Shannon Reidt, Pharm.D., MPH, Kristin K. Janke, PhD and Jenifer L Morgan, PharmD
University of Minnesota College of Pharmacy, Minneapolis, MN

69

Teaching HIV management to pharmacy students: Taking the clinic to the classroom

Lisa Inge, PharmD, BCPS, BCACP, AAHIVE
University of Florida, Colege of Pharmacy, Jacksonville, FL

70

Student use of insulin pumps as an empathy exercise

Ashley W. Ellis, Pharm.D., BCACP¹, Matthew Strum, PharmD, BCACP, CDE², Anastasia B. Jenkins, Pharm.D.³ and John Bentley, BS, MBA, PhD⁴
1University of Mississippi, University, TN
2Department of Pharmacy Practice, University of Mississippi School of Pharmacy, University, MS
3University of Mississippi, University, MS
4Department of Pharmacy Administration, University of Mississippi School of Pharmacy, University, MS

71

Research competencies and preparedness among hospital practicing pharmacists in Qatar

Ahmed Awaisu, Ph.D.¹, Dana Bakdach, BSc(Pharm)¹, Reem H. Elajez, BSc(Pharm)¹ and Manal Al Zaidan, BSc(Pharm)²
1College of Pharmacy, Qatar University, Doha, Qatar
2Heart Hospital and NCCCR, Hamad Medical Corporation, Doha, Qatar

72

The State of Nuclear Pharmacy Education in ACPE-Accredited Colleges of Pharmacy

Edward M. Bednarczyk, PharmD, Samuel Miller, PharmD and Mark Sauberan, BS
University at Buffalo, Buffalo, NY

73

Clinical communication skills compared with written and oral examination performance

Lisa M. Lundquist, PharmD, BCPS, Angela O. Shogbon, PharmD, BCPS and Kathryn M. Momary, PharmD, BCPS
Mercer University College of Pharmacy and Health Sciences, Atlanta, GA

74

Communication of clinical recommendations during oral examinations

Lisa M. Lundquist, PharmD, BCPS, Angela O. Shogbon, PharmD, BCPS and Kathryn M. Momary, PharmD, BCPS
Mercer University College of Pharmacy and Health Sciences, Atlanta, GA

75E

Evaluation of pharmacy students' clinical interventions on advanced pharmacy practice experiences at a non-teaching hospital

Angela O. Shogbon, PharmD, BCPS and Lisa M. Lundquist, PharmD, BCPS
Mercer University College of Pharmacy and Health Sciences, Atlanta, GA

76

Student pharmacists' perception of a service learning experience at a charity pharmacy

Lauren S. Bloodworth, PharmD, BCPS, Meagan Brown, PharmD, Courtney Davis, PharmD and Leigh Ann Ross, PharmD, BCPS
University of Mississippi School of Pharmacy, Jackson, MS

77

Incorporation of human patient simulation into an antimicrobial stewardship based infectious diseases elective

Bonnie A. Falcione, PharmD, BCPS(AQ-ID), Susan M. Meyer, PhD and Amy L. Seybert, PharmD, FASHP, FCCP
University of Pittsburgh School of Pharmacy, Pittsburgh, PA

78

SOAP Note written documentation needs assessment and course methodology evaluation for on-line course

Ann M. Snyder, PharmD
Pharmacotherapy & Translational Research, University of Florida, Gainesville, FL

79

Etomidate vs. Non-Etomidate Induction for Rapid Sequence Intubation in Trauma

Elizabeth Hand, Pharm.D.¹, Michael Corneille, MD², Kay Green, R.Ph., BCPS¹, Pam Maxwell, Pharm.D., BCPS¹ and Darrel W. Hughes, Pharm.D., BCPS¹
1University Health System, San Antonio, TX
2UTHSCSA, San Antonio, TX

80

Intravenous Sodium Bicarbonate Therapy in Severely Acidotic Diabetic Ketoacidosis

Bryson Duhon, Pharm.D.¹, Ana Crystal Franco-Martinez, Pharm.D., BCPS¹, Rebecca Attridge, Pharm.D., MS., BCPS², Pam Maxwell, Pharm.D., BCPS¹ and Darrel W. Hughes, Pharm.D., BCPS¹
1University Health System, San Antonio, TX
2University of the Incarnate Word Feik School of Pharmacy, San Antonio, TX

81

Heparin therapy for venous thromboembolism: are morbidly obese patients treated differently?

Suprat Saely, PharmD, BCPS¹, Brian Badgley, PharmD¹ and Peter Whittaker, PhD²
1Detroit Receiving Hospital, Detroit, MI
2Wayne State University School of Medicine, Cardiovascular Research Institute and Dept of Emergency Medicine, Detroit, MI

82

Hypotension associated with propofol in trauma patients in the emergency department

Amanda E. Shearin, PharmD¹, Asad E. Patanwala, PharmD, BCPS², Andrew Tang, MD¹ and Brian L. Erstad, PharmD¹
1University of Arizona, Tucson, AZ
2The University of Arizona College of Pharmacy, Tucson, AZ

83

From sunset to sunrise: the role and potential value of newly established night-shift emergency department pharmacists in a community regional medical center

Sandra C. Bartlett, PhD, PharmD, BCPS, Brooke M. Bitner, PharmD and Katherine E. Burenheide, MS, PharmD, BCPS
Stormont-Vail HealthCare, Topeka, KS

84

Pharmacist-led diabetes chronic care management program improves glycemic control without increasing costs in patients with uncontrolled type 2 diabetes

Carrie McAdam-Marx, PhD, RPh¹, Brandon T. Jennings, PharmD², Arati Dahal, PhD¹ and Karen Gunning, Pharm.D.³
1University of Utah Pharmacotherapy Outcomes Research Center, Salt Lake City, UT
2University of Utah College of Pharmacy, Salt Lake City, UT
3University of Utah Departments of Pharmacotherapy & Family and Preventive Medicine, Salt Lake City, UT

85E

Evaluation of the use of different insulin regimens in the treatment of type1 and type 2 diabetes mellitus

Maha Mahmoud Al Hakim, Master, in, Clinical, Pharmacy¹, Abobakr Abasaeed, Pharm, D, in, Pharmacy² and D.Jones Jones, Professor³
1Mafraq Hospital.Inpatient Pharmacy.Drug Information Centre.Abu Dhabi.UAE, Abu Dhabi, United Arab Emirates
2Ministry of Health, Abu Dhabi, United Arab Emirates
3Queen University .Belfast.Irland.UK, Belfast, United Kingdom

86

Impact of an interdisciplinary inpatient diabetes education process on patient understanding and adherence

Amanda Lin, Pharm.D.¹, Kim C. Coley, Pharm.D.², Rima A. Mohammad, PharmD, BCPS² and Amy C. Donihi, PharmD²
1University of Pittsburgh Medical Center, Pittsburgh, PA
2University of Pittsburgh School of Pharmacy, Pittsburgh, PA

87

A retrospective analysis of vitamin D practice patterns in a Veterans Affairs Medical Center

Elizabeth A. Connolly, PharmD¹, Debra W. Kemp, PharmD, BCPS, BCACP² and Karen Barnard, MD³
1UNC Eshelman School of Pharmacy, Chapel Hill, NC
2UNC Eshelman School of Pharmacy / Durham VA Medical Center, Durham, NC
3Durham VA Medical Center, Durham, NC

91

Opportunities for quality improvement in long term care (LTC): Medication related contributors to falls among older residents of a retirement community

Carlos Rojas-Fernandez, PharmD¹, Susan G. Brown, MSc² and Josie d'Avernas, MSc²
1University Of Waterloo School of Pharmacy/Schlegel-UW Research Institute for Aging, Kitchener, ON, Canada
2Schlegel-UW Research Institute for Aging, Kitchener, ON, Canada

93

Results of a pharmacist-managed anticoagulation service at a long-term care facility

Haley M. Phillippe, Pharm.D
Harrison School of Pharmacy, Brownsboro, AL

95

Effectiveness of a Pharmacy Care Management Program for Veterans with Dyslipidemia

Michael C. Smith, PharmD¹, Amy S. Boldt, PharmD¹, Cassandra M. Walston, PharmD¹ and Alan J. Zillich, PharmD²
1Richard L. Roudebush VA Medical Center, Indianapolis, IN
2Purdue University College of Pharmacy, Indianapolis, IN

96

Self-control by patients of the medication list compared to medication verification with pharmacist

Anders Ekedahl, PhD
Medical Products Agency, Uppsala, Sweden

97E

Characterizing Financial Burden of Pulmonary Hypertension Within an Integrated Healthcare Delivery System

Samuel G. Johnson, PharmD, BCPS, (AQ, -, Card), Adrian Larkin, PharmD, Paul B. Shaw, PharmD, BCPS and Thomas Delate, PhD
Kaiser Permanente, Aurora, CO

98

Quality and outcomes assessment of intravenous unfractionated heparin anticoagulation in venous thromboembolism

Christine P. Rash, Pharm.D.¹, Ruchi Patel, Pharm.D., BCPS¹, Keri Bicking, Pharm.D., BCPS, BCNSP¹, Luigi Brunetti, PharmD², Brian Faley, Pharm.D., BCPS², Zachariah Thomas, Pharm.D., BCPS² and Massimo Napolitano, MD¹
1Hackensack University Medical Center, Hackensack, NJ
2Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ

99

Impact of platelet functional assays on the cost of treating suspected heparin induced thrombocytopenia (HIT)

Ziad Sadik, PharmD, Douglas L. Jennings, PharmD, BCPS, (AQ-CV), Carrie W. Nemerovski, PharmD, BCPS, (AQ-CV) and James S. Kalus, PharmD, BCPS, (AQ-CV)
Henry Ford Hospital, Detroit, MI

101E

Evaluating standardized weight based heparin nomogram vs. patient specific dosing to achieve and maintain targeted activated partial thromboplastin time (aPTT) at a quaternary care teaching hospital

Leslie Varikattu, Pharm.D., Samrah Ahmad, Pharm.D. and Rehana Jamali, Pharm.D.
North Shore University Hospital, Manhasset, NY

102

Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic

Mark Donaldson, BSP, PHARMD, FASHP, FACHE and Amber Norbeck, PHARMD
Kalispell Regional Medical Center, Kalispell, MT

103

Effect of Patient Self-Testing on Chronic Anticoagulation

Cindy Leslie A. Arocena, PharmD and Stacey Dean, PharmD, BCPS
Virginia Commonwealth University Health System, Richmond, VA

149E

Omega-3 long-chain polyunsaturated fatty acids attenuate bile acid-induced apoptosis via Fas-dependent pathways

Emma M. Tillman, Pharm.D.¹, Richard A. Helms, Pharm.D.² and Dennis D. Black, M.D.¹
1University of Tennessee Health Science Center, Memphis, TN
2University of Tennessee, Memphis, TN

151

Correlation of EGFR (epidermal growth factor receptor) mutation status with Gefitinib response rate used as second-line therapy in patient with metastatic non-small-cell Lung Cancer

Sagar pravinchandra Kansara, M.Pharm.
A.R.College of Pharmacy and Hemato -oncology clinic,Vedanta institute of medical sciences, Ahmedabad, India

152E

Phase I results of decitabine in combination with midostaurin (PKC412) for elderly (age ≥ 60) newly diagnosed or relapsed/refractory adult patients with AML

Casey B. Williams, Pharm.D., BCOP¹, Suman Kambhampati, MD², Siddhartha Ganguly, MD², Omar Aljitawi, MD², Jo Wick, PhD², Ruben Reyes, MD², Allan Fleming, MD², Kapil Bhalla, MD², Sunil Abhyankar, MD² and Joseph McGuirk, DO²
1Sanford Research/USD, Sioux Falls, SD
2University of Kansas Medical Center, Kansas City, KS

153

Efficacy of Single Dose Rasburicase in Prophylaxis and Treatment of Tumor Lysis Syndrome: A metaanalysis

Xiaodong Feng, PhD, PharmD, Kevin Dong, PharmD Student, Dan Pham, PharmD Student, John Inciardi, PharmD, D.Sci. and Nilesh Bhutada, PhD
California Northstate University College of Pharmacy, Rancho Cordova, CA

154E

An evaluations of the incidence of proteinuria and hypertension in patients receiving shorter infusions of bevacizumab

Sachin R. Shah, PharmD, BCOP¹ and Sarah M. Gressett Ussery, Pharm.D., BCOP²
1Texas Tech University Health Sciences Center School of Pharmacy/ VA North Texas Health Care System;, Dallas, TX
2Bristol Myers Squibb, Waxahachie, TX

155

Pilot Study: Valproic Acid Effectiveness in Minimizing Incidence of Seizures in Postoperative Pediatric Brain Tumor Patients

Sherif Kamal, director, of, Departement, of, Pharmaceutical, Service¹, Maggie M. Abbassi, PhD², Sherif Abouelnaga, PhD³ and Azza M. Agha, PhD⁴
1Children Cancer Hospital Egypt 57357, Cairo, Egypt
2Faculty of Pharmacy, Cairo, Egypt
3Children cancer Hospital Egypt, Cairo, Egypt
4faculty of Pharmacy, Cairo, Egypt

156

High-Dose Bolus Interleukin-2: Correlating Response Rate with Number of Doses Received

Jolly Patel, PharmD, Dawn Goetz, PharmD, BCOP, Mayer Fishman, MD, PhD and Ragini Kudchadkar, MD
H. Lee Moffitt Cancer Center, Tampa, FL

157

Investigating the in vivo effects of dexamethasone using a human disease relevant mouse model of glioblastoma

Amira Hosni-Ahmed, BS¹, Ken Pitter, BS², Eric Holland, MD, PhD² and Terreia Jones, PharmD¹
1University of Tennessee Health Science Center, Memphis, TN
2Memorial Sloan-Kettering Cancer Center, New York, NY

158

Obesity and carboplatin dosing in gynecologic oncology patients

Cory R. Bivona, Pharm.D.¹, Susan Klenke, RPh, BCOP¹, Gary Johnson, MD² and Casey B. Williams, Pharm.D., BCOP³
1University of Kansas Hospital, Kansas City, KS
2University of Kansas Cancer Center, Kansas City, KS
3Sanford Research/USD, Sioux Falls, SD

183

A descriptive analysis of medication adherence and mortality among elderly post-MI patients

Tasneem Lokhandwala, MS¹, Matthew Strum, PharmD, BCACP, CDE², Yi Yang, MD, PhD³, John Bentley, BS, MBA, PhD¹ and Benjamin Banahan III, PhD⁴
1University of Mississippi School of Pharmacy, University, MS
2Department of Pharmacy Practice, University of Mississippi School of Pharmacy, University, MS
3Department of Pharmacy Administration, University of Mississippi School of Pharmacy, University, MS
4Center for Pharmaceutical Marketing and Management, University of Mississippi School of Pharmacy, University, MS

184

Identification of Adverse Drug Events Post-Hospital Discharge in a Geriatric Population

Jennifer L. Donovan, PharmD¹, Abir O Kanaan, PharmD¹, Jennifer Tjia, MD, MSCE², Terry S. Field, DSc², Shawn Gagne, BS³, Lawrence Garber, MD⁴, Sarah L Cutrona, MD, MPH³, Leslie R Harrold, MD, MPH³, Peggy Preusse, RN, George Reed, PhD⁶ and Jerry H Gurwitz, MD³
1MCPHS University, Worcester, MA
2Meyers Primary Care Institute, a joint endeavor of the University of Massachusetts Medical School, Reliant Medical Group, and Fallon Community Health Plan, Worcester, MA
3Meyers Primary Care Institute, University of Massachusetts Medical School, Worcester, MA
4Reliant Medical Group, Worcester, MA
5University of Massachusetts medical School, Worcester, MA

185

Cardiovascular thromboembolic events associated with use of Febuxostat: Investigation of case reports from the FDA adverse event reporting system database

Pranav K. Gandhi, PhD, William M. Gentry, Pharm.D. and Michael Bottorff, Pharm.D., FCCP, FNLA, CLS
South College School of Pharmacy, Knoxville, TN

186

Identification of bleeding adverse events associated with the concurrent administration of Dabigatran and Dronedarone: Investigation of case reports from the FDA adverse event reporting system database

Pranav K. Gandhi, PhD, William M. Gentry, Pharm.D. and Michael Bottorff, Pharm.D., FCCP, FNLA, CLS
South College School of Pharmacy, Knoxville, TN

187E

Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae in Community Hospitals: A Case-Case-Control Study

Grace C. Lee, Pharm.D, BCPS¹, Donna R. Burgess, RPH², Kurt R. Winkler, Pharm.D., MHA, BCPS³ and David S. Burgess, Pharm.D., FCCP¹
1University of Texas at Austin College of Pharmacy and University of Texas Health Science Center School of Medicine, San Antonio, TX
2Methodist Hospital Department of Pharmacy and University of Texas at Austin College of Pharmacy, San Antonio, TX
3Methodist Hospital Department of Pharmacy, San Antonio, TX

190

Association between CYP2C9 genetic polymorphism and the pharmaockinetics and pharmacodynamics of glipizide

Byung-Sung Kang, Ph.D., Candidate, Hye-In Lee, M.S. and Chang-Ik Choi, Ph.D.
School of Pharmacy, Sungkyunkwan University, Suwon, South Korea

219E

Effects of Pharmacist Drug Regimen Reviews on Physicians' Compliance with Recommended Laboratory Monitoring Criteria for Psychotropic Medications at a State Supported Living Center

Abimbola Farinde, PharmD, MS, BCPP, CGP
Clear Lake Regional Medical Center, Webster, TX

220E

Second generation antipsychotic prescribing patterns for veterans with posttraumatic stress disorder over a ten-year period

Marshall E. Cates, Pharm.D, BCPP, FASHP¹, Lori L. Davis, M.D.², Ekaette E. Ebong, Pharm.D.² and Joette S. Lowe, Pharm.D.²
1Samford University McWhorter School of Pharmacy, Birmingham, AL
2VA Medical Center, Tuscaloosa, AL

224E

Tapentadol abuse: the first 18 months

Richard C. Dart, MD, PhD¹, Edgar H. Adams, Sc.D.², Becki B. Bucher-Bartelson, PhD¹, Gary M. Baker, Pharm.D.³, Janet K. Pitner, Pharm.D., MBA³ and Gary J. Vorsanger, PhD, MD³
1Rocky Mountain Poison and Drug Center, Denver, CO
2Covance Market Access, Gaithersburg, MD
3Janssen Scientific Affairs, LLC, Raritan, NJ

225

Contributions of the Orphan Drug Act: Agents for solid organ transplantation

Christopher R. Ensor, PharmD¹, Timothy R. Cote, MD, MPH² and Lili A. Barouch, MD³
1The Johns Hopkins Hospital, Baltimore, MD
2Keck Graduate Institute, Claremont, CA
3Johns Hopkins University, Baltimore, MD

226E

Single Center Experience with Prospective BK Monitoring in Renal Transplantation

Jennifer Trofe-Clark, Pharm, D, BCPS¹, Simin Goral, MD², Deirdre Sawinski, MD², Melissa Bleicher, MD², Matthew H. Levine, MD³, Peter L Abt, MD³, Lauren Ende-Schwartz, MD⁴, Vivanna Vandeerlin, MD, PhD⁴ and Roy D. Bloom, MD²
1Hospital of the Univ of Pennsylvania Pharmacy Services and Renal Division, Perelman School of Medicine, Univ of Pennsylvania, Philadelphia, PA
2Renal Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
3Division of Transplant Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
4Hospital of the University of Pennsylvania, Department of Pathology and Laboratoyr Medicine, Philadelphia, PA

228E

Evaluation of outcomes following positive crossmatch renal transplantation despite failure to convert to negative crossmatch after desensitization

Shree Patel, PharmD, Jamie Joseph, PharmD, Sanjeev Akkina, MD, James Thielke, PharmD, Maya Campara, PharmD, Patricia West-Thielke, PharmD, Jose Oberholzer, MD and Enrico Benedetti, MD
University of Illinois Hospital and Health Sciences System, Chicago, IL

229E

A pharmacokinetic comparison of a generic tacrolimus versus reference in subpopulations of kidney transplant recipients

Jennifer Trofe-Clark, Pharm.D., BCPS¹, Roy D. Bloom, MD², Anne Wiland, PharmD, BCPS³, Basma Sadaka, PharmD, BCPS⁴ and Rita R. Alloway, Pharm, D, BCPS, FCCP⁴
1Hospital of the Univ of Pennsylvania, Pharmacy Services, Renal Division, Perelman School of Medicine, Univ of Pennsylvania, Philadelphia, PA
2Renal Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
3Novartis Pharmaceuticals Corporation, East Hanover, NJ
4Section of Transplantation, University of Cinncinati, Cincinnati, OH

230E

Evaluation of Medication Education and Adherence of Patients Being Evaluated for Kidney and/or Pancreas Transplantation

Tiffany R. Shin, PharmD¹, April Delahunty, PharmD, BCPS², Holli A. Winters, Pharm.D., BCPS², Donna M. Smolen, BSN, CNN², Aneeka R. Qureshi, PharmD, Candidate¹ and Maria Pruchnicki, Pharm, D, BCPS, CLS¹
1The Ohio State University College of Pharmacy, Columbus, OH
2The Ohio State University Wexner Medical Center, Columbus, OH

231

Four-year outcomes after corticosteroid withdrawal in kidney transplant patients: An analysis from the Mycophenolic Acid Observational Renal Transplant Registry

Lonnie Smith, Pharm.D.¹, Anne Wiland, PharmD, BCPS², V. Ram Peddi, MD³ and Kimi Ueda, Pharm.D.³
1University of Utah Hospitals and Clinics, Salt Lake City, UT
2Novartis Pharmaceuticals Corporation, East Hanover, NJ
3California Pacific Medical Center, San Francisco, CA

232

Impact of Cytokine Gene Polymorphism on BK Virus Nephropathy in a Large Cohort of Kidney Transplant Recipients

Don Vu, PharmD, &, Ph.D¹, Prashant Sakharkar, Pharm.D, &, MPH², Tariq Shah, M.D.³, Robert Naraghi, M.D.³, Ian V. Hutchinson, Ph.D., DSc⁴ and David I. Min, Pharm.D.⁵
1National Institute of Transplantation and Western University of Health Sciences, College of Pharmacy, Los Angeles, CA
2Western University Health of Sciences, Pomona, CA
3National Institue of Transplantation and St. Vincent Medical Center, Los Angeles, CA
4USC School of Pharmacy, Los Angeles, CA
5Western University of Health Sciences, College of Pharmacy and National Institute of Transplantation, Los Angeles, CO

233

Intravenous immunoglobulin (IVIG) as rescue therapy for BK virus nephropathy

Don Vu, PharmD, &, Ph.D¹, Tariq Shah, M.D.², Robert Naraghi, M.D.², Ian V. Hutchinson, Ph.D.³ and David I. Min, Pharm.D.⁴
1National Institute of Transplantation and Western University of Health Sciences, Los Angeles, CA
2National Institue of Transplantation and St. Vincent Medical Center, Los Angeles, CA
3USC School of Pharmacy, Los Angeles, CA
4Western University of Health Sciences, College of Pharmacy and National Institute of Transplantation, Los Angeles, CA

234

Outcomes at four years after kidney transplantation in African-American kidney transplant patients in the era of modern immunosuppression: An analysis from the Mycophenolic Acid Observational Renal Transplant Registry

Lonnie Smith, Pharm.D.¹, Anne Wiland, PharmD, BCPS² and Ali Olyaei, Pharm., D.³
1University of Utah Hospitals and Clinics, Salt Lake City, UT
2Novartis Pharmaceuticals Corporation, East Hanover, NJ
3Oregon State University and Oregon Health and Science University, Portland, OR

235

A four-year analysis of immunosuppressive regimens and outcomes in Expanded Criteria Donor kidney transplant recipients from the Mycophenolic Acid Observational Renal Transplant Registry

Ali Olyaei, Pharm.D¹, V. Ram Peddi, MD², Anne Wiland, PharmD, BCPS³ and Kimi Ueda, Pharm.D²
1Oregon State University and Oregon Health and Science University, Portland, OR
2California Pacific Medical Center, San Francisco, CA
3Novartis Pharmaceuticals Corporation, East Hanover, NJ

236

A comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil to four years after kidney transplantation: An analysis from the Mycophenolic Acid Observational Renal Transplant Registry

Ali Olyaei, Pharm.D¹, Anne Wiland, PharmD, BCPS² and Lonnie Smith, Pharm.D³
1Oregon State University and Oregon Health and Science University, Portland, OR
2Novartis Pharmaceuticals Corporation, East Hanover, NJ
3University of Utah Hospitals and Clinics, Salt Lake City, UT

237

Thymoglobulin Versus Simulect Induction in Hepatitis C Positive Kidney Transplant Recipients

Kwaku Marfo, Pharm.D., MPH¹, Manhal Olaywi, MD², Javier Chapochnick, MD³, Milan Kinkhabwala, MD³, Stuart Greenstein, MD³, Liise Kayler, MD³, Michele Lubetzky, MD³, Graciella De Boccardo, MD³ and Enver Akalin, MD³
1Montefiore-Einstein Center for Transplantation, Montefiore Medical Center, Bronx, NY
2Brooklyn Hospital Center, Brooklyn, NY
3Montefiore Medical Center, Bronx, NY

238

Incidence of invasive fungal infections following aerosolized amphotericin B lipid complex as sole prophylaxis in adult lung transplant recipients

Rachael E. Waterson, PharmD, Neha Patel, PharmD, BCPS and Richard Drew, PharmD, MS, BCPS, FCCP
Duke University Hospital, Durham, NC

239

Efficacy and Safety of 3 vs. 6 Months of Low-Dose Valganciclovir for Prevention of Cytomegalovirus Disease in Moderate-Risk (D+/R+ and D-/R+) Renal Transplant Recipients Receiving Antilymphocyte Antibody Induction Therapy

Steven Gabardi, PharmD¹, Rosemary Cross, PharmD², Kelly DePiero, PharmD³, Travis B. Dick, PharmD, BCPS⁴, Angela Q. Maldonado, Pharm, D, BCPS⁵, Pamela R. Maxwell, Pharm.D., BCPS⁶, Joelle Nelson, Pharm.D.⁷, Kathleen Nguyen, PharmD⁸, Jeong M. Park, M.S., Pharm.D.⁹, Eric M. Tichy, Pharm.D., BCPS¹⁰, Kimi Ueda, Pharm.D.¹¹, Renee Weng, Pharm.D.¹² and Erin N. Newkirk, Pharm.D.¹³
1Department of Pharmacy & Renal Divison, Brigham & Women's Hospital; Department of Medicine, Harvard Medical School, Boston, MA
2Piedmont Hospital, Atlanta, GA
3Lahey Clinic Medical Center, Burlington, MA
4Intermountain Medical Center, Murray, UT
5Sacred Heart Medical Center, Spokane, WA
6University Transplant Center, The University of Texas Health Science Center at San Antonio, San Antonio, TX
7University Health System, San Antonio, TX
8University of California Irvine Medical Center, Orange, CA
9University of Michigan, Ann Arbor, MI
10Yale-New Haven Hospital, New Haven, CT
11California Pacific Medical Center, San Francisco, CA
12UC-Irvine, Orange, CA
13Froedtert & the Medical College of Wisconsin, Milwaukee, WI

240E

Incidence of supratherapeutic tacrolimus troughs before and after implementation of an initial dosing protocol in orthotopic heart transplantation

Tracy M. Sparkes, Pharm.D.¹, Tamara Claridge, Pharm.D., BCPS², Todd A. Miano, Pharm.D., BCPS², Erin H. Ticehurst, Pharm.D.² and Lee R. Goldberg, MD, MPH, FACC²
1Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA
2Hospital of the University of Pennsylvania, Philadelphia, PA

241E

Impact of optimization of antiviral therapy and removal of cytomegalovirus immune globulin on clinical outcomes in liver and combined liver/kidney transplant recipients

Jennifer Jebrock, PharmD, BCPS¹, Venessa Price, PharmD¹, Alexandra Centeno, PharmD¹, Lilian Abbo, MD², Michele Morris, MD² and Andreas G Tzakis, MD²
1Jackson Memorial Hospital, Miami, FL
2University of Miami Miller School of Medicine, Miami, FL

242

Prevention of Cytomegalovirus Disease in Moderate-Risk (D+/R+ and D-/R+) Renal Transplant Recipients Receiving Basiliximab Induction Therapy: an Efficacy and Safety Evaluation of 3 vs. 6 Months of Low-Dose Valganciclovir

Steven Gabardi, PharmD¹, Rosemary Cross, PharmD², Kelly DePiero, PharmD³, Travis B. Dick, PharmD, BCPS⁴, Pamela R. Maxwell, Pharm.D., BCPS⁵, Joelle Nelson, Pharm.D.⁶, Erin N. Newkirk, Pharm.D.⁷, Kathleen Nguyen, PharmD⁸, Jeong M. Park, M.S., Pharm.D.⁹, Eric M. Tichy, Pharm.D., BCPS¹⁰, Kimi Ueda, Pharm.D.¹¹, Renee Weng, Pharm.D.¹² and Angela Q. Maldonado, Pharm, D, BCPS¹³
1Department of Pharmacy & Renal Divison, Brigham & Women's Hospital; Department of Medicine, Harvard Medical School, Boston, MA
2Piedmont Hospital, Atlanta, GA
3Lahey Clinic Medical Center, Burlington, MA
4Intermountain Medical Center, Murray, UT
5University Transplant Center, The University of Texas Health Science Center at San Antonio, San Antonio, TX
6University Health System, San Antonio, TX
7Froedtert & the Medical College of Wisconsin, Milwaukee, WI
8University of California Irvine Medical Center, Orange, CA
9University of Michigan, Ann Arbor, MI
10Yale-New Haven Hospital, New Haven, CT
11California Pacific Medical Center, San Francisco, CA
12UC-Irvine, Orange, CA
13Sacred Heart Medical Center, Spokane, WA

243

Effect of Thymoglobulin on the Development of BK Virus Viruria and Viremia in Renal Transplant Recipients: A Case-Control Study

Allison L. Mruk, PharmD¹, Yevgeniya Gokun, MS², Thomas H. Waid, M.D.¹, Carol Broughton, APRN¹ and Timothy M. Clifford, Pharm.D., BCPS¹
1University of Kentucky Chandler Medical Center, Lexington, KY
2University of Kentucky College of Pharmacy, Lexington, KY

244

Investigation of the HPV vaccine, Gardasil: Are patients completing the series as recommended?

Lori Ernsthausen, PharmD, Brinda Dave, Pharm.D. Candidate, Christine Osborn, Pharm.D. Candidate and Amanda Palgut, Pharm.D. Candidate
The University of Findlay College of Pharmacy, Findlay, OH

245

Preliminary study of FMO3, MSRA, and AOX1 gene polymorphisms on pharmacokinetics of sulindac and its metabolites

Kyungeun Lee, Pharm.D.¹, Nara Lee, MS¹, Sunny Park, BS¹, Byungkoo Lee, Ph.D.¹, Youngju Kim, M.D., Ph.D.² and Hyesun Gwak, Ph.D., Pharm.D.¹
1Division of Life and Pharmaceutical Sciences, Ewha Womans University, Seoul, South Korea
2Department of Obstetrics and Gynecology, Ewha Womans University School of Medicine, Seoul, South Korea